In oral cancer, ANLN activation leads to phosphorylation of PI3K, mTOR, AKT, and PDK-1, resulting in markedly elevated pathway activity that promotes tumor development (Wang B. et al., 2021). This evidence concerns the gene AKT1 and neoplasm.